 |
iTherX is focusing on finding novel approaches to treatment refractory solid tumors. We are using a scientific understanding of the biochemistry and immunology of these tumors to attack them.
>>>read more |
|
|
 |
iTherX has made unique and proprietary discoveries about how the hepatitis C virus attacks liver cells. We are using this information to derive new classes of drugs for treatment.
>>>read more |
|
|
 |
WHAT’S NEW?
December 17 , 2007
iTherX names Jeffrey F. McKelvy President and CEO... |
|
| |
|
 |
|
